Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-7522-8_9
Reference15 articles.
1. Chiang JP, Trzupek K (2015) The current status of molecular diagnosis of inherited retinal dystrophies. Curr Opin Ophthalmol 26:346–351. https://doi.org/10.1097/ICU.0000000000000185
2. Hung SS, McCaughey T, Swann O et al (2016) Genome engineering in ophthalmology: application of CRISPR/Cas to the treatment of eye disease. Prog Retin Eye Res 53:1–20. https://doi.org/10.1016/j.preteyeres.2016.05.001
3. McCaughey T, Sanfilippo PG, Gooden GE et al (2016) A global social media survey of attitudes to human genome editing. Cell Stem Cell 18:569–572. https://doi.org/10.1016/j.stem.2016.04.011
4. Mali P, Yang L, Esvelt KM et al (2013) RNA-guided human genome engineering via Cas9. Science 339:823–826. https://doi.org/10.1126/science.1232033
5. Day TP, Byrne LC, Schaffer DV et al (2014) Advances in AAV vector development for gene therapy in the retina. Adv Exp Med Biol 801:687–693. https://doi.org/10.1007/978-1-4614-3209-8_86
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques;Expert Opinion on Biological Therapy;2022-09-02
2. Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications;Journal of Controlled Release;2022-03
3. Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization;Scientific Reports;2022-02-14
4. Gene-Based Therapeutics for Inherited Retinal Diseases;Frontiers in Genetics;2022-01-07
5. Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing;Frontiers in Cellular Neuroscience;2020-09-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3